Ankur Dhingra - May 31, 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Stock symbol
SMMT
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/2/2022, 05:29 PM
Previous filing
Mar 28, 2022
Next filing
Mar 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +600K 600K May 31, 2022 Common Stock 600K $1.33 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date).
F2 Not applicable.